Clinical Pharmacy Activities Documented (ClinPhADoc): Development, Reliability and Acceptability of a Documentation Tool for Community Pharmacists.

community pharmacy documentation system drug-related problems pharmaceutical intervention validation

Journal

Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532

Informations de publication

Date de publication:
02 Dec 2019
Historique:
received: 20 09 2019
revised: 21 11 2019
accepted: 26 11 2019
entrez: 8 12 2019
pubmed: 8 12 2019
medline: 8 12 2019
Statut: epublish

Résumé

Documentation of community pharmacists' clinical activities, such as the identification and management of drug-related problems (DRPs), is recommended. However, documentation is not systematic in Swiss community pharmacies, and relevant information about DRPs, such as consequences or involved partners, is frequently missing. This study aims to evaluate the interrater and test-retest reliability, appropriateness and acceptability of the Clinical Pharmacy Activities Documented (ClinPhADoc) tool. Ten community pharmacists participated in the study. Interrater reliability coefficients were computed using 24 standardized cases. One month later, test-retest reliability was assessed using 10 standardized cases. To assess the appropriateness, pharmacists were asked to document clinical activities in their own practice using ClinPhADoc. Acceptability was assessed by an online satisfaction survey. Kappa coefficients showing a moderate level of agreement (>0.40) were observed for interrater and test-retest reliability. Pharmacists were able to document 131 clinical activities. The good level of acceptability and brief documentation time (fewer than seven minutes) indicate that ClinPhADoc is well-suited to the community pharmacy setting. To optimize the tool, pharmacists proposed developing an electronic version. These results support the reliability and acceptance of the ClinPhADoc tool.

Identifiants

pubmed: 31810295
pii: pharmacy7040162
doi: 10.3390/pharmacy7040162
pmc: PMC6958443
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Pharm World Sci. 2008 Dec;30(6):777-86
pubmed: 18392732
Ann Pharmacother. 2007 Nov;41(11):1825-32
pubmed: 17925500
Ann Pharmacother. 2015 Apr;49(4):405-18
pubmed: 25614526
Int J Clin Pharm. 2012 Feb;34(1):43-52
pubmed: 22101425
Am J Health Syst Pharm. 2007 Jul 15;64(14):1516-25
pubmed: 17617503
Pharm World Sci. 1999 Dec;21(6):245-50
pubmed: 10658231
Phys Ther. 2005 Mar;85(3):257-68
pubmed: 15733050
J Clin Epidemiol. 1992 Oct;45(10):1045-51
pubmed: 1474400
Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):275-80
pubmed: 18248511
J Clin Pharm Ther. 2012 Jun;37(3):276-81
pubmed: 21790687
Am J Health Syst Pharm. 2003 Apr 1;60(7):705-7
pubmed: 12701556
J Eval Clin Pract. 2019 Jun;25(3):476-481
pubmed: 30575217
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Pharm World Sci. 2006 Aug;28(4):222-32
pubmed: 17066238
Integr Pharm Res Pract. 2016 Mar 07;5:19-25
pubmed: 29354535
J Interprof Care. 2014 Sep;28(5):440-6
pubmed: 24716620
J Eval Clin Pract. 2017 Dec;23(6):1425-1432
pubmed: 28960678
Can J Hosp Pharm. 2017 Nov-Dec;70(6):423-429
pubmed: 29299001
Res Social Adm Pharm. 2015 Sep-Oct;11(5):602-22
pubmed: 25640887
Implement Sci. 2015 Oct 29;10:151
pubmed: 26514874
Am J Hosp Pharm. 1990 Mar;47(3):533-43
pubmed: 2316538
BMC Health Serv Res. 2011 Jan 13;11:9
pubmed: 21232111
Drug Saf. 2000 Jun;22(6):415-23
pubmed: 10877036
Pharm World Sci. 2010 Jun;32(3):362-72
pubmed: 20229029
J Med Internet Res. 2013 Oct 28;15(10):e212
pubmed: 24165786
DICP. 1990 Nov;24(11):1093-7
pubmed: 2275235
BMC Public Health. 2012 Mar 15;12:192
pubmed: 22420693
Pharmacotherapy. 2008 Jun;28(6):816-7
pubmed: 18503408
Res Social Adm Pharm. 2019 Feb;15(2):145-153
pubmed: 29709530
Can J Hosp Pharm. 2016 Mar-Apr;69(2):176-8
pubmed: 27168642
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3073-6
pubmed: 18049498
J Clin Pharm Ther. 2009 Jun;34(3):319-27
pubmed: 19646078
Pharm World Sci. 2002 Aug;24(4):120-7
pubmed: 12227243
Int J Clin Pharm. 2017 Apr;39(2):354-363
pubmed: 28251442

Auteurs

Nour Hamada (N)

Institute of Global Health of Geneva, University of Geneva, 1202 Geneva, Switzerland.
Community Pharmacy of the Center for Primary Care and Public Health (Unisanté), 1011 Lausanne, Switzerland.
Pharmaceutical Care Research Group, University of Basel, 4056 Basel, Switzerland.

Patricia Quintana Bárcena (P)

Community Pharmacy of the Center for Primary Care and Public Health (Unisanté), 1011 Lausanne, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, 1011 Lausanne, Switzerland.

Karen Alexandra Maes (KA)

Pharmaceutical Care Research Group, University of Basel, 4056 Basel, Switzerland.

Olivier Bugnon (O)

Community Pharmacy of the Center for Primary Care and Public Health (Unisanté), 1011 Lausanne, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, 1011 Lausanne, Switzerland.

Jérôme Berger (J)

Community Pharmacy of the Center for Primary Care and Public Health (Unisanté), 1011 Lausanne, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, 1011 Lausanne, Switzerland.

Classifications MeSH